Journal
PROTEOMICS
Volume 15, Issue 11, Pages 1813-1818Publisher
WILEY-BLACKWELL
DOI: 10.1002/pmic.201400242
Keywords
2D DIGE; AR; Cell biology; DHT; IGF-1; IGF1R
Funding
- Fondazione SDN-IRCCS
- Progetto FIRB Italian Human Proteomenet [RBRN07BMCT]
- Ministry of Health [GR-2010-2317596]
- CREME (Campania Research in Experimental Medicine) grant (Regione Campania) [CUP B25B09000050007]
Ask authors/readers for more resources
The abuse of mixed or combined performance-enhancing drugs is widespread among athletes and amateurs, adults and adolescents. Clinical studies demonstrated that misuse of these doping agents is associated with serious adverse effects to many organs in human. Previously, we demonstrated in human peripheral blood lymphocytes that high doses of anabolic androgenic steroids, such as dihydrotestosterone (DHT) and growth factors, such as insulin-like growth factor-1 (IGF-1), have effects at gene and protein levels. Supraphysiological treatments of DHT and IGF-1 affected the expression of genes involved in skeletal muscle disorders as well as in cell-mediated immunological response. At protein level, DHT hyperdosage affects cell motility and apoptosis; IGF-1 hyperstimulation triggers an active cytoskeletal reorganization and an overproduction of immune response- and inflammation-related cytokines. In this study, we investigate the combined effects of DHT and IGF-1 hyperdosage in peripheral blood lymphocytes using a differential proteomic approach. DHT and IGF-1 combined treatment affects cell adhesion, migration, and survival through modulation of expression levels of cytokines and paxillin-signaling-related proteins, and activation of several pathways downstream focal adhesion kinase. Our results indicate a synergistic effect of DHT and IGF-1 which has potential implications for health risk factors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available